4 Einträge gefunden

1. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

   1. Ludwig, Heinz
   2. Terpos, Evangelos
   3. van de Donk, Niels
   4. Mateos, Maria-Victoria
   5. Moreau, Philippe
   6. Dimopoulos, Melitios-Athanasios
   7. Delforge, Michel

   2023 - Forschungsinformationssystem des UKE
2. Real-world study on adoption of standard-of-care for transplant-eligible newly diagnosed multiple myeloma patients between 2017 and 2020/2021 across France, Germany, Spain, and Italy

   1. Weisel, Katja
   2. Wadlund, Astrid Ottosson
   3. Gungor, Guntug
   4. Dergarabetian, Eileen
   5. Pacheco, Cécile
   6. Masurkar, Nihar
   7. Rodriguez-Otero, Paula

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: a subanalysis of OPTIMISMM by clinical characteristics

   1. Richardson, Paul G
   2. Schjesvold, Fredrik
   3. Weisel, Katja
   4. Moreau, Philippe
   5. Anderson, Larry D
   6. White, Darrell
   7. Rodriguez-Otero, Paula

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma

   1. Rodriguez-Otero, Paula
   2. Ayers, Dieter
   3. Cope, Shannon
   4. Davies, Faith E
   5. Delforge, Michel
   6. Mojebi, Ali
   7. Jansen, Jeroen P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich